Imaging Flow Cytometry for High-Throughput Single-Cell Drug Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cell-based phenotypic drug screening methods are limited by low throughput due to the lack of two-dimensional spatial resolution and imaging capabilities in flow cytometers, necessitating subsequent high-resolution microscopy, which restricts the speed of analysis.
Innovation Solution
An imaging flow cytometry-based method that combines flow technology with high-speed microscopy to generate multi-channel single-cell images, incorporating fluorescent labeling and AI analysis to extract morphological and molecular information from cells treated with candidate drugs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional flow cytometry is used for high-throughput screening, then detection speed is improved, but spatial resolution and morphological information are lost
Solution Approach 1:
The patent merges flow cytometry technology with high-speed microscopy to create an imaging flow cytometer that combines the high-throughput capabilities of flow cytometry with the spatial resolution and morphological imaging capabilities of microscopy, resolving the contradiction between detection speed and measurement precision
Solution Approach 2:
The imaging flow cytometer performs multiple functions simultaneously: it detects scattered light and fluorescence signals like conventional flow cytometers while also acquiring two-dimensional spatial images of cells, making the system universal for both high-throughput screening and morphological analysis
2Measurement precision
If high-resolution fluorescence microscopy is used for precise analysis, then morphological information is improved, but throughput is reduced
Solution Approach 1:
The patent combines the high-resolution imaging capability of fluorescence microscopy with the high-speed particle delivery of flow cytometry, enabling the system to capture detailed morphological information of individual cells at thousands of cells per second, thus improving both measurement precision and productivity simultaneously
Solution Approach 2:
The patent replaces the traditional mechanical stage movement of microscopes with a flowing cell suspension system, where cells are delivered through a flow cell at high speed while being imaged, substituting mechanical positioning with fluid dynamics to achieve both high resolution and high throughput
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-throughput drug screening by increasing efficiency 102-104 times, allowing for rapid identification of suitable drugs based on cell morphology, organelle distribution, and protein expression, while reducing the need for subsequent microscopy.
Implementation Method 1
detect scattered light and fluorescence signals of biological particles
Implementation Method 2
detect scattered light and fluorescence signals of biological particles
Data Source
AI summary
An imaging flow cytometry-based high-throughput drug screening method, comprising: cell incubation, cell staining, acquiring single-cell images by using a flow cytometer, and image extraction and analysis, which combines the high-throughput advantages of flow cytometry and the imaging capability of a microscope, so that multi-channel single-cell images can be generated in a high throughput manner, thereby implementing acquisition of fluorescent images and unmarked images of single cells at a throughput of 102-105 cells per second, which can be used for cell phenotype drug screening and improving the screening efficiency by a factor of 102-104.